Atrium Therapeutics, Inc.

NASDAQ:RNA

Biotechnology

Healthcare
$6.64 +1.28%

+$0.16 today

Market cap
$143.23M
Beta
0.42
P/E (TTM)
-3.3
EPS (TTM)
-$3.78
52W Low $11.40High $16.77

Volume 0.22M

Average 0.35M

RNA Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

Atrium Therapeutics, Inc.NASDAQ: RNA

Income Tax Expense · Q1 FY2026 · quarter ended Mar 2026

Income tax expense of $0 in Q1 FY2026

Q1 FY2026 income tax expense was $0.

Context

  • Income tax expense amounted to 0.8% of revenue in FY2025.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0-100.0% QoQ
Last fiscal yearDec 2025
-$142K— YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Tax Expense history

USD · from the income statement

Latest · FY2025
(142K) USD
Year-over-year change
—

Income Tax Expense vs competitors

How RNA compares with its peers on the latest reported figures

No competitor Income Tax Expense figures are available to compare.

Atrium Therapeutics, Inc.

NASDAQ:RNA

Intrinsic Alpha fair value

Locked

Current Price

$6.64

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.